SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-18-001777
Filing Date
2018-03-16
Accepted
2018-03-16 16:58:06
Documents
117
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2234139z10-k.htm 10-K 1381549
2 EX-21.1 a2234139zex-21_1.htm EX-21.1 3347
3 EX-23.1 a2234139zex-23_1.htm EX-23.1 4015
4 EX-31.1 a2234139zex-31_1.htm EX-31.1 8027
5 EX-31.2 a2234139zex-31_2.htm EX-31.2 8168
6 EX-32.1 a2234139zex-32_1.htm EX-32.1 4528
7 EX-32.2 a2234139zex-32_2.htm EX-32.2 4483
14 G900262.JPG g900262.jpg GRAPHIC 56484
  Complete submission text file 0001047469-18-001777.txt   8358945

Data Files

Seq Description Document Type Size
8 EX-101.INS ontx-20171231.xml EX-101.INS 1840585
9 EX-101.SCH ontx-20171231.xsd EX-101.SCH 95190
10 EX-101.CAL ontx-20171231_cal.xml EX-101.CAL 54354
11 EX-101.DEF ontx-20171231_def.xml EX-101.DEF 335229
12 EX-101.LAB ontx-20171231_lab.xml EX-101.LAB 662666
13 EX-101.PRE ontx-20171231_pre.xml EX-101.PRE 575037
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 18696398
SIC: 2834 Pharmaceutical Preparations